Department of Pharmacy - Pharmaceutical Sciences, University of Bari Aldo Moro, via E. Orabona n. 4, 70126, Bari, Italy.
Department of Pharmacy and Biotechnologies, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, Bologna, 40126, Italy.
ChemMedChem. 2021 Feb 4;16(3):578-588. doi: 10.1002/cmdc.202000692. Epub 2020 Oct 28.
Under the hypothesis that cardioprotective agents might benefit from synergism between antiarrhythmic activity and antioxidant properties, a small series of mexiletine analogues were coupled with the 2,2,5,5-tetramethylpyrroline moiety, known for its antioxidant effect, in order to obtain dual-acting drugs potentially useful in the protection of the heart against post-ischemic reperfusion injury. The pyrroline derivatives reported herein were found to be more potent as antiarrhythmic agents than mexiletine and displayed antioxidant activity. The most interesting tetramethylpyrroline congener, a tert-butyl-substituted analogue, was at least 100 times more active as an antiarrhythmic than mexiletine.
基于这样一种假设,即心脏保护剂可能会受益于抗心律失常活性和抗氧化特性之间的协同作用,因此将一组小的美西律类似物与 2,2,5,5-四甲基吡咯烷部分偶联,该部分已知具有抗氧化作用,以便获得具有潜在心脏保护作用的双重作用药物缺血再灌注损伤。本文报道的吡咯烷衍生物被发现比美西律具有更强的抗心律失常作用,并且具有抗氧化活性。最有趣的四甲基吡咯烷同系物,叔丁基取代的类似物,作为抗心律失常剂的活性比美西律至少高出 100 倍。